Alpha Paradigm Partners’s DexCom DXCM Stock Holding History

Alpha Paradigm Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.47M	Buy	13,008 +9,871	+315%	+$1.08M	0.61%	34
2022 Q3	$253K	Buy	+3,137	New	+$266K	0.11%	261

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha Paradigm Partners's DXCM Position: Q4 2022 in Review

Alpha Paradigm Partners increased its DexCom (DXCM) stake by 315% in Q4 2022, buying an estimated $1.08M and bringing the position to 13,008 shares worth $1.47M. The position accounts for 0.61% of the portfolio, ranked #34.

Alpha Paradigm Partners first reported a position in DXCM in Q3 2022 and has held it in 2 quarters since. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

Alpha Paradigm Partners held 13,008 shares of DexCom worth $1.47M as of Q4 2022.
Alpha Paradigm Partners bought 9,871 DexCom shares in Q4 2022, an estimated $1.08M.
DexCom made up 0.61% of Alpha Paradigm Partners's portfolio in Q4 2022, its #34 holding.
Alpha Paradigm Partners first reported a position in DexCom in Q3 2022 and has held it in 2 quarters since.
920 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.